The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
Open accessAbstract
Human JAK2 tyrosine kinase mediates signaling through numerous cytokine receptors. The JAK2 JH2 domain functions as a negative regulator and is presumed to be a catalytically inactive pseudokinase, but the mechanism(s) for its inhibition of JAK2 remains unknown. Mutations in JH2 lead to increased JAK2 activity, contributing to myeloproliferative neoplasms (MPNs). Here we show that JH2 is a dual-specificity protein kinase that phosphorylates two negative regulatory sites in JAK2: Ser523 and Tyr570. Inactivation of JH2 catalytic activity increased JAK2 basal activity and downstream signaling. Notably, different MPN mutations abrogated JH2 activity in cells, and in MPN (V617F) patient cells phosphorylation of Tyr570 was reduced, suggesting that loss of JH2 activity contributes to the pathogenesis of MPNs. These results identify the catalytic activity of JH2 as a previously unrecognized mechanism to control basal activity and signaling of JAK2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,942
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Self-citationRegulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1226 · Cited by 1,372
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276
Protein Tyrosine Kinase Structure and Function
Hubbard, S. R., & Till, J. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.373 · Cited by 1,171
Self-citationYamaoka, K., Saharinen, P., Pesu, M., Holt, V. E., Silvennoinen, O., & O'Shea, J. J. (2004) · Genome Biology · doi:10.1186/gb-2004-5-12-253 · Cited by 635
Self-citationHighly selective enrichment of phosphorylated peptides using titanium dioxide
Thingholm, T. E., Jørgensen, T. J. D., Jensen, O. N., & Larsen, M. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.185 · Cited by 618
Self-citationImada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610 · cited 1×
“2099" language="eng" relation="no"> JAK2 belongs to the Janus family of cytoplasmic tyrosine kinases ( JAK1 – JAK3 , TYK2 ) and functions as a crucial mediator of signaling for hematopoietic cytokines and hormones such as erythropoietin ( Epo ), thrombopoietin ( Tpo ), interferon-γ ( IFN-γ ), several interleukins, gro…”
Emerging roles of pseudokinases
Boudeau, J., Miranda-Saavedra, D., Barton, G. J., & Alessi, D. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.003 · Cited by 547
Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., & Ihle, J. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8429 · Cited by 501
Self-citationErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Shi, F., Telesco, S. E., Liu, Y., Radhakrishnan, R., & Lemmon, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002753107 · Cited by 471
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
Self-citationStructure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
Zeqiraj, E., Filippi, B. M., Deak, M., Alessi, D. R., & van Aalten, D. M. F. (2009) · Science · doi:10.1126/science.1178377 · Cited by 365
Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3
Jura, N., Shan, Y., Cao, X., Shaw, D. E., & Kuriyan, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912101106 · Cited by 338
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61341-0 · Cited by 337
Saharinen, P., & Silvennoinen, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205156200 · Cited by 318
Self-citationCASK Functions as a Mg2+-independent neurexin kinase
Mukherjee, K., Sharma, M., Urlaub, H., Bourenkov, G. P., Jahn, R., Südhof, T. C., & Wahl, M. C. (2008) · Cell · doi:10.1016/j.cell.2008.02.036 · Cited by 271
Lucet, I. S., Fantino, E., Styles, M., Bamert, R., Patel, O., Broughton, S. E., Walter, M., Burns, C. J., Treutlein, H., Wilks, A. F., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2413 · Cited by 266
Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain
Saharinen, P., Vihinen, M., & Silvennoinen, O. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0342 · Cited by 216
Self-citationMin, X., Lee, B.-H., Cobb, M. H., & Goldsmith, E. J. (2004) · Structure · doi:10.1016/j.str.2004.04.014 · Cited by 208
Signaling by Type I and II cytokine receptors: ten years after
Gadina, M., Hilton, D., Johnston, J. A., Morinobu, A., Lighvani, A., Zhou, Y.-J., Visconti, R., & O'Shea, J. J. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00228-4 · Cited by 206
Scheeff, E. D., Eswaran, J., Bunkoczi, G., Knapp, S., & Manning, G. (2009) · Structure · doi:10.1016/j.str.2008.10.018 · Cited by 194
Structure and functional characterization of the atypical human kinase haspin
Eswaran, J., Patnaik, D., Filippakopoulos, P., Wang, F., Stein, R. L., Murray, J. W., Higgins, J. M. G., & Knapp, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901989106 · Cited by 176
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog
Boggon, T. J., Li, Y., Manley, P. W., & Eck, M. J. (2005) · Blood · doi:10.1182/blood-2005-02-0707 · Cited by 170
Pseudokinases-remnants of evolution or key allosteric regulators?
Zeqiraj, E., & van Aalten, D. M. F. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.10.001 · Cited by 151
Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity
Argetsinger, L. S., Kouadio, J.-L. K., Steen, H., Stensballe, A., Jensen, O. N., & Carter‐Su, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4955-4967.2004 · Cited by 146
Self-citationChen, M., Cheng, A., Candotti, F., Zhou, Y.-J., Hymel, A., Fasth, A. L., Notarangelo, L. D., & O’Shea, J. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.947-956.2000 · Cited by 141
Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling
Feener, E. P., Rosario, F., Dunn, S. L., Stancheva, Z. S., & Myers, M. G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4968-4978.2004 · Cited by 129
Optimized IMAC−IMAC Protocol for Phosphopeptide Recovery from Complex Biological Samples
Ye, J., Zhang, X., Young, C., Zhao, X., Hao, Q., Cheng, L., & Jensen, O. N. (2010) · Journal of Proteome Research · doi:10.1021/pr100075x · Cited by 112
Self-citationJAK2 inhibitors: What's the true therapeutic potential?
Santos, F. P. D. S., & Verstovšek, S. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.10.004 · Cited by 72
Phosphorylation of Jak2 on Ser 523 InhibitsJak2-Dependent Leptin ReceptorSignaling
Ishida-Takahashi, R., Rosario, F., Gong, Y., Kopp, K., Stancheva, Z. S., Chen, X., Feener, E. P., & Myers, M. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01589-05 · Cited by 65
Haan, C., Behrmann, I., & Haan, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01018.x · Cited by 64
Mazurkiewicz-Muñoz, A. M., Argetsinger, L. S., Kouadio, J.-L. K., Stensballe, A., Jensen, O. N., Cline, J. M., & Carter‐Su, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01591-05 · Cited by 63
Self-citationDetermination of the transphosphorylation sites of Jak2 kinase
Matsuda, T., Feng, J., Witthuhn, B. A., Sekine, Y., & Ihle, J. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.071 · Cited by 53
Regulation of Jak2 Function by Phosphorylation of Tyr317 and Tyr637 during Cytokine Signaling
Robertson, S., Koleva, R., Argetsinger, L. S., Carter‐Su, C., Marto, J. A., Feener, E. P., & Myers, M. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00278-09 · Cited by 46
Argetsinger, L. S., Stuckey, J. A., Robertson, S., Koleva, R., Cline, J. M., Marto, J. A., Myers, M. G., & Carter‐Su, C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0355 · Cited by 39
Hall, T., Emmons, T. L., Chrencik, J., Gormley, J. A., Weinberg, R. A., Leone, J. W., Hirsch, J. L., Saabye, M. J., Schindler, J. F., Day, J. E., et al. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.09.011 · Cited by 22
Cited by
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, J. J., Schwartz, D. M., Villarino, A. V., Gadina, M., McInnes, I. B., & Laurence, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051113-024537 · Cited by 1,599
Mechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0701-9 · Cited by 1,206
The molecular details of cytokine signaling via the JAK/STAT pathway
Morris, R., Kershaw, N. J., & Babon, J. J. (2018) · Protein Science · doi:10.1002/pro.3519 · Cited by 943
Metadata
- Authors
- Ungureanu, D., Wu, J., Pekkala, T., Niranjan, Y., Young, C., Jensen, O. N., Xu, C.-F., Neubert, T. A., Skoda, R. C., Hubbard, S. R., & Silvennoinen, O.
- Venue
- Nature Structural & Molecular Biology
- Published
- 2011-08-14
- Volume
- 18
- Issue
- 9
- Pages
- 971-976
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W1966969980
- Cited by
- 276
- References
- 39
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.